Strata Skin Sciences (SSKN) Competitors

$0.15 +0.02 (+18.97%)

As of 03:47 PM Eastern

SSKN vs. IVF, NUWE, AMIX, BBLG, and BLAC

Should you buy Strata Skin Sciences stock or one of its competitors? MarketBeat compares Strata Skin Sciences with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Strata Skin Sciences include INVO Fertility (IVF), Nuwellis (NUWE), Autonomix Medical (AMIX), Bone Biologics (BBLG), and Bellevue Life Sciences Acquisition (BLAC). These companies are all part of the "medical equipment" industry.

How does Strata Skin Sciences compare to INVO Fertility?

INVO Fertility (NASDAQ:IVF) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

INVO Fertility presently has a consensus price target of $20.00, suggesting a potential upside of 1,165.82%. Given INVO Fertility's stronger consensus rating and higher possible upside, research analysts plainly believe INVO Fertility is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INVO Fertility	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.50
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, INVO Fertility and INVO Fertility both had 1 articles in the media. Strata Skin Sciences' average media sentiment score of 0.00 beat INVO Fertility's score of -0.64 indicating that Strata Skin Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
INVO Fertility	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Strata Skin Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Strata Skin Sciences has a net margin of -35.64% compared to INVO Fertility's net margin of -417.02%. INVO Fertility's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INVO Fertility	-417.02%	N/A	-92.42%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 0.7% of INVO Fertility shares are owned by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

INVO Fertility has a beta of 2.31, meaning that its stock price is 131% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, meaning that its stock price is 105% less volatile than the broader market.

INVO Fertility has higher earnings, but lower revenue than Strata Skin Sciences. Strata Skin Sciences is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INVO Fertility	$6.53M	0.39	-$9.10M	-$3.15 thousand	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

Summary

INVO Fertility beats Strata Skin Sciences on 8 of the 15 factors compared between the two stocks.

How does Strata Skin Sciences compare to Nuwellis?

Nuwellis (NASDAQ:NUWE) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, analyst recommendations, earnings, valuation, dividends and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nuwellis	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Strata Skin Sciences has a net margin of -35.64% compared to Nuwellis' net margin of -214.90%. Strata Skin Sciences' return on equity of -476.73% beat Nuwellis' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nuwellis	-214.90%	-32,351.83%	-249.08%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Nuwellis has a beta of 0.25, indicating that its share price is 75% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, indicating that its share price is 105% less volatile than the broader market.

3.1% of Nuwellis shares are held by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are held by institutional investors. 1.6% of Nuwellis shares are held by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Strata Skin Sciences has higher revenue and earnings than Nuwellis. Strata Skin Sciences is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nuwellis	$8.27M	0.32	-$17.52M	-$64.02	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

In the previous week, Nuwellis and Nuwellis both had 1 articles in the media. Strata Skin Sciences' average media sentiment score of 0.00 beat Nuwellis' score of -0.27 indicating that Strata Skin Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nuwellis	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Strata Skin Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Strata Skin Sciences beats Nuwellis on 9 of the 12 factors compared between the two stocks.

How does Strata Skin Sciences compare to Autonomix Medical?

Autonomix Medical (NASDAQ:AMIX) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Autonomix Medical currently has a consensus price target of $2.00, indicating a potential upside of 401.25%. Given Autonomix Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Autonomix Medical is more favorable than Strata Skin Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Autonomix Medical has a beta of -1.82, meaning that its share price is 282% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, meaning that its share price is 105% less volatile than the broader market.

Autonomix Medical has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Autonomix Medical's return on equity of -228.82% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-228.82%	-186.65%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Strata Skin Sciences has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$11.41M	-$3.55	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 6.2% of Autonomix Medical shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Autonomix Medical had 1 more articles in the media than Strata Skin Sciences. MarketBeat recorded 2 mentions for Autonomix Medical and 1 mentions for Strata Skin Sciences. Autonomix Medical's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Autonomix Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Strata Skin Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Strata Skin Sciences beats Autonomix Medical on 7 of the 13 factors compared between the two stocks.

How does Strata Skin Sciences compare to Bone Biologics?

Bone Biologics (NASDAQ:BBLG) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, earnings, risk, valuation, institutional ownership, media sentiment, dividends and analyst recommendations.

Bone Biologics has higher earnings, but lower revenue than Strata Skin Sciences. Bone Biologics is trading at a lower price-to-earnings ratio than Strata Skin Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$2.27	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

Bone Biologics has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Bone Biologics' return on equity of -50.47% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-50.47%	-47.40%
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 6.1% of Bone Biologics shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Bone Biologics has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market.

In the previous week, Bone Biologics had 6 more articles in the media than Strata Skin Sciences. MarketBeat recorded 7 mentions for Bone Biologics and 1 mentions for Strata Skin Sciences. Bone Biologics' average media sentiment score of 0.75 beat Strata Skin Sciences' score of 0.00 indicating that Bone Biologics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bone Biologics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Strata Skin Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Bone Biologics beats Strata Skin Sciences on 7 of the 11 factors compared between the two stocks.

How does Strata Skin Sciences compare to Bellevue Life Sciences Acquisition?

Bellevue Life Sciences Acquisition (NASDAQ:BLAC) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

In the previous week, Strata Skin Sciences had 1 more articles in the media than Bellevue Life Sciences Acquisition. MarketBeat recorded 1 mentions for Strata Skin Sciences and 0 mentions for Bellevue Life Sciences Acquisition. Bellevue Life Sciences Acquisition's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company	Overall Sentiment
Bellevue Life Sciences Acquisition	Neutral
Strata Skin Sciences	Neutral

Bellevue Life Sciences Acquisition has higher earnings, but lower revenue than Strata Skin Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bellevue Life Sciences Acquisition	N/A	N/A	N/A	N/A	N/A
Strata Skin Sciences	$30.98M	0.03	-$10.09M	-$1.41	N/A

55.3% of Bellevue Life Sciences Acquisition shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 33.7% of Bellevue Life Sciences Acquisition shares are owned by insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Bellevue Life Sciences Acquisition has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. Bellevue Life Sciences Acquisition's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bellevue Life Sciences Acquisition	N/A	N/A	N/A
Strata Skin Sciences	-35.64%	-476.73%	-33.49%

Bellevue Life Sciences Acquisition has a beta of -0.08, suggesting that its stock price is 108% less volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of -0.05, suggesting that its stock price is 105% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bellevue Life Sciences Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Strata Skin Sciences	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Strata Skin Sciences beats Bellevue Life Sciences Acquisition on 5 of the 9 factors compared between the two stocks.

Get Strata Skin Sciences News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SSKN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SSKN vs. The Competition

Export

Metric	Strata Skin Sciences	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$883K	$1.46B	$6.34B	$12.29B
Dividend Yield	N/A	N/A	2.79%	5.32%
P/E Ratio	-0.06	41.77	17.81	22.73
Price / Sales	0.03	6.34	524.48	77.74
Price / Cash	N/A	22.77	44.13	56.13
Price / Book	0.13	6.36	9.99	7.01
Net Income	-$10.09M	-$54.76M	$3.55B	$335.05M
7 Day Performance	15.22%	7.42%	0.42%	-0.29%
1 Month Performance	15.31%	11.04%	-0.05%	1.15%
1 Year Performance	-94.00%	1.23%	35.06%	34.79%

Strata Skin Sciences Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SSKN Strata Skin Sciences	0.1959 of 5 stars	$0.15 +19.0%	N/A	-94.8%	$883K	$30.98M	N/A	120
IVF INVO Fertility	1.6084 of 5 stars	$1.59 -1.6%	$20.00 +1,161.8%	-99.4%	$2.60M	$6.53M	N/A	10	News Coverage Positive News
NUWE Nuwellis	0.3499 of 5 stars	$1.03 -1.0%	N/A	-97.5%	$2.56M	$8.27M	N/A	70	Gap Down
AMIX Autonomix Medical	1.9059 of 5 stars	$0.33 -1.6%	$2.00 +506.2%	-81.2%	$2.32M	N/A	N/A	1	Positive News Analyst Upgrade
BBLG Bone Biologics	1.2008 of 5 stars	$1.30 +1.6%	N/A	-76.7%	$2.30M	N/A	N/A	2	Earnings Report Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SSKN) was last updated on 5/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Strata Skin Sciences (SSKN) Competitors

SSKN vs. IVF, NUWE, AMIX, BBLG, and BLAC

How does Strata Skin Sciences compare to INVO Fertility?

Summary

How does Strata Skin Sciences compare to Nuwellis?

Summary

How does Strata Skin Sciences compare to Autonomix Medical?

Summary

How does Strata Skin Sciences compare to Bone Biologics?

Summary

How does Strata Skin Sciences compare to Bellevue Life Sciences Acquisition?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Strata Skin Sciences (SSKN) Competitors

SSKN vs. IVF, NUWE, AMIX, BBLG, and BLAC

How does Strata Skin Sciences compare to INVO Fertility?

Do analysts prefer IVF or SSKN?

Does the media favor IVF or SSKN?

Is IVF or SSKN more profitable?

Do institutionals and insiders have more ownership in IVF or SSKN?

Which has more volatility and risk, IVF or SSKN?

Which has better valuation & earnings, IVF or SSKN?

Summary

How does Strata Skin Sciences compare to Nuwellis?

Do analysts prefer NUWE or SSKN?

Is NUWE or SSKN more profitable?

Which has more volatility & risk, NUWE or SSKN?

Do insiders and institutionals hold more shares of NUWE or SSKN?

Which has higher earnings and valuation, NUWE or SSKN?

Does the media refer more to NUWE or SSKN?

Summary

How does Strata Skin Sciences compare to Autonomix Medical?

Do analysts rate AMIX or SSKN?

Which has more volatility & risk, AMIX or SSKN?

Is AMIX or SSKN more profitable?

Which has higher valuation & earnings, AMIX or SSKN?

Do insiders & institutionals believe in AMIX or SSKN?

Does the media prefer AMIX or SSKN?

Summary

How does Strata Skin Sciences compare to Bone Biologics?

Which has preferable earnings & valuation, BBLG or SSKN?

Is BBLG or SSKN more profitable?

Do analysts rate BBLG or SSKN?

Do insiders & institutionals have more ownership in BBLG or SSKN?

Which has more risk and volatility, BBLG or SSKN?

Does the media favor BBLG or SSKN?

Summary

How does Strata Skin Sciences compare to Bellevue Life Sciences Acquisition?

Does the media favor BLAC or SSKN?

Which has better valuation and earnings, BLAC or SSKN?

Do insiders & institutionals hold more shares of BLAC or SSKN?

Is BLAC or SSKN more profitable?

Which has more volatility and risk, BLAC or SSKN?

Do analysts prefer BLAC or SSKN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SSKN vs. The Competition

Strata Skin Sciences Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools